CUFinder

Karen Lane

Karen Lane

Johns Hopkins University

H-index: 25

North America-United States

Contact Karen Lane

About Karen Lane

Karen Lane, With an exceptional h-index of 25 and a recent h-index of 24 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of stroke.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical Trial Protocol for BEACH: A Phase 2a Study of MW189 in Patients with Acute Nontraumatic Intracerebral Hemorrhage

Erratum for Gebo et al.,“Early antibody treatment, inflammation, and risk of post-COVID conditions”

Trial readiness of cavernous malformations with symptomatic hemorrhage, part I: event rates and clinical outcome

Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience

Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded, phase 2 …

Development, implementation, and dissemination of operational innovations across the trial innovation network

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned

Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling

Karen Lane Information

University

Position

___

Citations(all)

4433

Citations(since 2020)

2719

Cited By

2629

hIndex(all)

25

hIndex(since 2020)

24

i10Index(all)

36

i10Index(since 2020)

29

Email

University Profile Page

Google Scholar

Karen Lane Skills & Research Interests

stroke

Top articles of Karen Lane

Clinical Trial Protocol for BEACH: A Phase 2a Study of MW189 in Patients with Acute Nontraumatic Intracerebral Hemorrhage

Neurocritical care

2024/4

W Andrew Mould
W Andrew Mould

H-Index: 11

Karen Lane
Karen Lane

H-Index: 17

Erratum for Gebo et al.,“Early antibody treatment, inflammation, and risk of post-COVID conditions”

Mbio

2024/1/16

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Daniel Hanley
Daniel Hanley

H-Index: 17

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Trial readiness of cavernous malformations with symptomatic hemorrhage, part I: event rates and clinical outcome

Stroke

2024/1

Helen Kim
Helen Kim

H-Index: 4

Romuald Girard
Romuald Girard

H-Index: 17

Reed Selwyn
Reed Selwyn

H-Index: 12

Robert Shenkar
Robert Shenkar

H-Index: 23

Karen Lane
Karen Lane

H-Index: 17

Ying Wang
Ying Wang

H-Index: 3

Richard Thompson
Richard Thompson

H-Index: 78

Timothy Carroll
Timothy Carroll

H-Index: 7

Daniel Hanley
Daniel Hanley

H-Index: 17

Issam Awad
Issam Awad

H-Index: 46

Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience

Contemporary Clinical Trials

2023/2/1

Gwenyth Fischer
Gwenyth Fischer

H-Index: 5

Riad Lutfi
Riad Lutfi

H-Index: 8

W Andrew Mould
W Andrew Mould

H-Index: 11

Karen Lane
Karen Lane

H-Index: 17

Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded, phase 2 …

Clinical infectious diseases

2023/2/1

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Daniel Hanley
Daniel Hanley

H-Index: 17

Bryan Lau
Bryan Lau

H-Index: 9

Kelly Gebo
Kelly Gebo

H-Index: 46

Adam C Levine
Adam C Levine

H-Index: 22

Arash Naeim
Arash Naeim

H-Index: 20

Lawrence Appel
Lawrence Appel

H-Index: 99

Anthony Bowen
Anthony Bowen

H-Index: 9

Stephan Ehrhardt
Stephan Ehrhardt

H-Index: 22

Donald Forthal
Donald Forthal

H-Index: 30

Sabra Klein
Sabra Klein

H-Index: 44

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Development, implementation, and dissemination of operational innovations across the trial innovation network

Journal of Clinical and Translational Science

2023/1

Michelle Jones
Michelle Jones

H-Index: 2

Karen Lane
Karen Lane

H-Index: 17

Paul A Harris
Paul A Harris

H-Index: 20

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned

Journal of Clinical and Translational Science

2023/1

W Andrew Mould
W Andrew Mould

H-Index: 11

Karen Lane
Karen Lane

H-Index: 17

Paul A Harris
Paul A Harris

H-Index: 20

Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling

medRxiv

2023

Romuald Girard
Romuald Girard

H-Index: 17

Helen Kim
Helen Kim

H-Index: 4

Robert Shenkar
Robert Shenkar

H-Index: 23

Karen Lane
Karen Lane

H-Index: 17

Ying Wang
Ying Wang

H-Index: 3

401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy

Open Forum Infectious Diseases

2023/12

Kelly Gebo
Kelly Gebo

H-Index: 46

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Laura Hammitt
Laura Hammitt

H-Index: 27

Donald Forthal
Donald Forthal

H-Index: 30

Adam C Levine
Adam C Levine

H-Index: 22

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Evan Bloch
Evan Bloch

H-Index: 24

Daniel Hanley
Daniel Hanley

H-Index: 17

Arturo Casadevall
Arturo Casadevall

H-Index: 80

David Sullivan
David Sullivan

H-Index: 3

Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network

Journal of clinical and translational science

2023/1

Karen Lane
Karen Lane

H-Index: 17

Sarah Nelson
Sarah Nelson

H-Index: 6

Paul Harris
Paul Harris

H-Index: 67

Early antibody treatment, inflammation, and risk of post-COVID conditions

Mbio

2023/10/31

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Daniel Hanley
Daniel Hanley

H-Index: 17

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Early Treatment, Inflammation and Post-COVID Conditions (preprint)

Mbio

2023/10/31

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Daniel Hanley
Daniel Hanley

H-Index: 17

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials

JAMA network open

2023/10/2

Paul A Harris
Paul A Harris

H-Index: 20

Karen Lane
Karen Lane

H-Index: 17

Sarah Nelson
Sarah Nelson

H-Index: 6

Brian Smith
Brian Smith

H-Index: 4

Vincent Miller
Vincent Miller

H-Index: 11

Michelle Jones
Michelle Jones

H-Index: 2

Lindsay Eyzaguirre
Lindsay Eyzaguirre

H-Index: 12

Ann Johnson
Ann Johnson

H-Index: 1

Gary Henderson
Gary Henderson

H-Index: 1

Tiffany Chen
Tiffany Chen

H-Index: 5

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

The Lancet Microbe

2023/9/1

Adam C Levine
Adam C Levine

H-Index: 22

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Daniel Hanley
Daniel Hanley

H-Index: 17

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

Transfusion

2023/9

Adam C Levine
Adam C Levine

H-Index: 22

Ying Wang
Ying Wang

H-Index: 3

Karen Lane
Karen Lane

H-Index: 17

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Stephan Ehrhardt
Stephan Ehrhardt

H-Index: 22

Bryan Lau
Bryan Lau

H-Index: 9

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Jiangda Ou
Jiangda Ou

H-Index: 1

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations.

Medrxiv: the Preprint Server for Health Sciences

2023/4/24

Adam C Levine
Adam C Levine

H-Index: 22

Karen Lane
Karen Lane

H-Index: 17

Bryan Lau
Bryan Lau

H-Index: 9

Stephan Ehrhardt
Stephan Ehrhardt

H-Index: 22

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

Blood advances

2022/6/28

Karen Lane
Karen Lane

H-Index: 17

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Adam C Levine
Adam C Levine

H-Index: 22

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Andrew Pekosz
Andrew Pekosz

H-Index: 32

How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?

Transfusion

2022/5

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Donald Forthal
Donald Forthal

H-Index: 30

Karen Lane
Karen Lane

H-Index: 17

Arturo Casadevall
Arturo Casadevall

H-Index: 80

David Sullivan
David Sullivan

H-Index: 3

High viral specific antibody convalescent plasma effectively neutralizes SARS-CoV-2 variants of concern

medRxiv

2022/3/2

Robert Mckie
Robert Mckie

H-Index: 0

Karen Lane
Karen Lane

H-Index: 17

Daniel Hanley
Daniel Hanley

H-Index: 17

Shmuel Shoham
Shmuel Shoham

H-Index: 29

Adam C Levine
Adam C Levine

H-Index: 22

Arturo Casadevall
Arturo Casadevall

H-Index: 80

Andrew Pekosz
Andrew Pekosz

H-Index: 32

Using gamification to enhance clinical trial start-up activities

Journal of Clinical and Translational Science

2022/1

Karen Lane
Karen Lane

H-Index: 17

Joshua Gruber
Joshua Gruber

H-Index: 12

Daniel Hanley
Daniel Hanley

H-Index: 17

See List of Professors in Karen Lane University(Johns Hopkins University)